Sitemap
Home
Company Profile
  - About us
  - History
  - Vision
  - Management
  - Board of Directors
  - Careers/jobs
  - Disclaimer
  - Contact us
Research & Development
  - R&D
  - Infection
  - - Medical need
  - - Market situation
  - Cancer
  - - Medical need
  - - Market situation
  - Pipeline
  - Publications
Investors
  - Investor relations
  - Shareholders
  - Pipeline
  - Presentations
  - Awards
  - Subscribe to our newsletter
Partners
  - Partnership strategy and licensing
  - Collaborations
  - Conferences
  - Subscribe to our newsletter
Media
  - Contact us
  - News archive
  - Presentations
  - Publications
  - Logo
  - Subscribe to our newsletter
Newsletter
News
  - News archive
September 01, 2010:
- Approval to start Phase IIa clinical trial with Lytixar™ (LTX-109)
Read more
Oslo, Norway and Seoul, Korea, June 09, 2010:
- Lytix Biopharma and KAEL–GemVax announce approval of joint clinical trial
Read more
May 20, 2010:
- Update on the Phase I clinical trials of Oncopore™ (LTX-315) for the treatment of cancer.
Read more
May 20, 2010:
- Approval by the Swedish Medical Products Agency to commence a Phase I/IIa clinical trial
Read more
Go to news archive >